Saccharomyces: Is it a probiotic or a pathogen and what is the significance of an elevated anti-S. cerevisiae antibody?

Journal of Clinical Gastroenterology

Volumn 36, Issue 1, 2003, Pages 5-6

  Floch, Martin H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN A; MICROSATELLITE DNA; PROBIOTIC AGENT;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; CELIAC DISEASE; CLOSTRIDIUM DIFFICILE; DIARRHEA; EDITORIAL; FUNGEMIA; IMMUNE DEFICIENCY; MICROSATELLITE MARKER; MYCOLOGY; PRIORITY JOURNAL; SACCHAROMYCES BOULARDII; SACCHAROMYCES CEREVISIAE; ULCERATIVE COLITIS;

ANTIBODIES, FUNGAL; COLITIS, ULCERATIVE; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; PROBIOTICS; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0037215088     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200301000-00003     Document Type: Editorial

References (11)

1. Riquelme AJ, Calvo MA, Guzmá AM, et al. Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients. J Clin Gastroenterol 2002;36:41-3.
2. Candelli M, Nista EC, Armuzzi A, et al. Saccharomyces cerevisiae-associated diarrhea in an immunocompetent patient with ulcerative colitis. J Clin Gastroenterol 2002;36:39-40.
3. Murray PR. Manual of clinical microbiology. 7th ed. Washington DC: ASM Press, 1999.
4. Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardi: A prospective study. Gastroenterology 1989;96:981-8.
5. Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease. BMJ 1988;297:1105-6.
6. McKenzle H, Main J, Pennington CR, et al. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut 1990;31:536-8.
7. Gaiffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992;33:1071-5.
8. Quinton J-F, Sendid B, Reumaux E, et al. Anti- Saccharomyces cerevisiae mannan antibodies combined with antineutrophilic cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 1998;42:788-91.
9. Annese V, Andreoli A, Andriulli A, et al. Familial expression of antiSaccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: A GISC study. Am J Gastroenterol 2001;96:2407-12.
10. Peeters M, Joossens S, Vermiere S, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophilic cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001;96:730-4.
11. Joossens S, Reinisch W, Vermeire S, et al. The value of serologic markers in indeterminate colitis: a prospective follow-up study. Gastroenterology 2002; 122:1242-7.